Your browser doesn't support javascript.
loading
Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.
Liu, Yuhong; Gao, Jingtao; Du, Jian; Shu, Wei; Wang, Lu; Wang, Yufeng; Xue, Zhongtan; Li, Liang; Xu, Shaofa; Pang, Yu.
Affiliation
  • Liu Y; Clinical Center on TB, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, 101149, P.R. China.
  • Gao J; Clinical Center on TB, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, 101149, P.R. China.
  • Du J; Clinical Center on TB, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, 101149, P.R. China.
  • Shu W; Clinical Center on TB, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, 101149, P.R. China.
  • Wang L; National Clinical Laboratory on Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, 101149, P.R. China.
  • Wang Y; Department of Laboratory Quality Control, Innovation Alliance on Tuberculosis Diagnosis and Treatment (Beijing), Beijing, 101149, P. R. China.
  • Xue Z; Department of Laboratory Quality Control, Innovation Alliance on Tuberculosis Diagnosis and Treatment (Beijing), Beijing, 101149, P. R. China.
  • Li L; Clinical Center on TB, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, 101149, P.R. China. Electronic address: liliang69@tb123.org.
  • Xu S; Clinical Center on TB, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, 101149, P.R. China. Electronic address: xushaofa@263.net.
  • Pang Y; National Clinical Laboratory on Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, 101149, P.R. China. Electronic address: pangyupound@163.com.
Int J Infect Dis ; 102: 392-396, 2021 Jan.
Article in En | MEDLINE | ID: mdl-33130209
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clofazimine / Tuberculosis, Multidrug-Resistant / Drug Resistance, Multiple, Bacterial / Diarylquinolines / Mycobacterium tuberculosis / Antitubercular Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clofazimine / Tuberculosis, Multidrug-Resistant / Drug Resistance, Multiple, Bacterial / Diarylquinolines / Mycobacterium tuberculosis / Antitubercular Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Type: Article